Ashwagandha-loaded nanocapsules improved the behavioral alterations, and blocked MAPK and induced Nrf2 signaling pathways in a hepatic encephalopathy rat model

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Khalil H.M.A.; Khalil I.A.; Al-Mokaddem A.K.; Hassan M.; El-Shiekh R.A.; Eliwa H.A.; Tawfek A.M.; El-Maadawy W.H.

Journal: Drug Delivery and Translational Research

Publisher: Springer

Publication Date: 7 June 2022

Volume / Issue: Volume 13 / Issue 1

Pages: 252–274

ISSN: 2190393X

DOI: 10.1007/s13346-022-01181-y

Scopus: View on Scopus

PubMed: 35672652

Document Type: Article

Access: All Open Access; Green Open Access; Hybrid Gold Open Access


Authors and Affiliations

Khalil H.M.A., Department of Veterinary Hygiene and Management, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt; Khalil I.A., Department of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University of Science and Technology (MUST), 6th of October, Giza, 12582, Egypt; Al-Mokaddem A.K., Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza Square, Giza, 12211, Egypt; Hassan M., Department of Immunology, Theodor Bilharz Research Institute, Kornaish El Nile, Warrak El-Hadar, Imbaba, P.O. 30, Giza, 12411, Egypt; El-Shiekh R.A., Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Kasr el Aini st., Cairo, 11562, Egypt; Eliwa H.A., Department of Pharmacology and Toxicology, College of Pharmacy and Drug Manufacturing, Misr University of Science and Technology (MUST), 6th October, Giza, 12566, Egypt; Tawfek A.M., Department of Clinical Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt; El-Maadawy W.H., Department of Pharmacology, Theodor Bilharz Research Institute, Kornaish El Nile, Warrak El-Hadar, Imbaba, P.O. 30, Giza, 12411, Egypt


Abstract

Ashwagandha (ASH), a vital herb in Ayurvedic medicine, demonstrated potent preclinical hepato- and neuroprotective effects. However, its efficacy is limited due to low oral bioavailability. Accordingly, we encapsulated ASH extract in chitosan–alginate bipolymeric nanocapsules (ASH-BPNCs) to enhance its physical stability and therapeutic effectiveness in the gastrointestinal tract. ASH-BPNC was prepared by emulsification followed by sonication. The NCs showed small particle size (< 220 nm), zeta-potential of 25.2 mV, relatively high entrapment efficiency (79%), physical stability at acidic and neutral pH, and in vitro release profile that extended over 48 h. ASH-BPNC was then investigated in a thioacetamide-induced hepatic encephalopathy (HE) rat model. Compared with free ASH, ASH-BPNC improved survival, neurological score, general motor activity, and cognitive task-performance. ASH-BPNC restored ALT, AST and ammonia serum levels, and maintained hepatic and brain architecture. ASH-BPNC also restored GSH, MDA, and glutathione synthetase levels, and Nrf2 and MAPK signaling pathways in liver and brain tissues. Moreover, ASH-BPNC downregulated hepatic NF-κB immunohistochemical expression. Moreover, the in vivo biodistribution studies demonstrated that most of the administered ASH-BPNC is accumulated in the brain and hepatic tissues. In conclusion, chitosan–alginate BPNCs enhanced the hepatoprotective and neuroprotective effects of ASH, thus providing a promising therapeutic approach for HE. Graphical abstract: [Figure not available: see fulltext.] © 2022, The Author(s).


Keywords

Ashwagandha; Bipolymeric nanocapsules; Cognition; Hepatic encephalopathy; MAPK pathway; Nrf2 pathway; Animals; Chitosan; Nanocapsules; Neuroprotective Agents; Plant Extracts; Rats; Signal Transduction; Tissue Distribution; alanine aminotransferase; ammonia; aspartate aminotransferase; glutathione synthase; malonaldehyde; nanocapsule; transcription factor Nrf2; Withania somnifera extract; neuroprotective agent; plant extract; animal experiment; animal model; animal tissue; Article; ash; Ayurveda; bioassay; chronic liver disease; controlled study; dispersity; liver toxicity; male; MAPK signaling; morphological trait; motor activity; nanopharmaceutics; nonhuman; Nrf2 signaling; particle size; practice guideline; rat; real time reverse transcription polymerase chain reaction; Withania somnifera; animal


Citation Information

Scopus Citations: 28


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer